HA

Hitesh Ashok Jain

Active Director Designated Partner DIN 10924245
DIN 10924245 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Hitesh Ashok Jain

Data last updated:

Hitesh Ashok Jain is a Designated Partner at Yugrow Pharmacy Llp (since 2025).

DIN 10924245
Primary Designation Designated Partner
First Appointment 27 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Jan 20252025Active

Board colleagues of Hitesh Ashok Jain

NameDINCompanyDesignation
Dilip Kishanlal Jain03497509Yugrow Pharmacy LlpDesignated Partner
Girish Kishanlal Jain03506505Yugrow Pharmacy LlpDesignated Partner
Kamlesh Kantilal Jain10480085Yugrow Pharmacy LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Yugrow Pharmacy Llp
Premium access

Shareholding and investment profile for Hitesh Ashok Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hitesh Ashok Jain

Hitesh Ashok Jain currently holds 1 directorship: Yugrow Pharmacy Llp (Designated Partner, since 27 Jan 2025).

Hitesh Ashok Jain was first appointed on 27 Jan 2025 as Designated Partner at Yugrow Pharmacy Llp.

The current boards of Hitesh Ashok Jain's companies include Dilip Kishanlal Jain (Yugrow Pharmacy Llp), Girish Kishanlal Jain (Yugrow Pharmacy Llp), Kamlesh Kantilal Jain (Yugrow Pharmacy Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available